Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically
related to low molecular weight heparins. It is marketed by GlaxoSmithKline.
Medscape - Indication-specific dosing for Arixtra (fondaparinux), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
Easy to read patient leaflet for fondaparinux. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Physician reviewed fondaparinux patient information - includes fondaparinux
description, dosage and directions.
Learn about Arixtra (Fondaparinux Sodium) may treat, uses, dosage, side effects,
drug interactions, warnings, patient labeling, reviews, and related medications.
Learn about indications, dosage and how it is supplied for the drug Arixtra (
Learn about clinical pharmacology for the drug Arixtra (Fondaparinux Sodium).
ARIXTRA® (fondaparinux sodium) Injection is a sterile solution containing
fondaparinux sodium. It is a synthetic and specific inhibitor of activated Factor X (
Oct 14, 2016 ... The first fondaparinux administration should be given not earlier than 6 hours
following surgical closure. The injection should not be given ...
May 31, 2016 ... Fondaparinux (Arixtra) is a synthetic anticoagulant based on the pentasaccharide
sequence that makes up the minimal antithrombin (AT) ...